Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Alba Therapeutics Announces the Creation of Its Corporate Advisory Board and the Appointment of VP Intellectual Property and General Counsel.


BALTIMORE -- Alba Therapeutics Corporation today announced the first appointments to its Corporate Advisory Board and also announced the appointment of Chris Jeffers, Ph.D., J.D. as General Counsel and Vice President Intellectual Property. Alba's first appointees to its Corporate Advisory Board are Tim Mayleben, MBA and Roger Newton, PhD. Dr. Newton was Founder and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Esperion Therapeutics, a company founded in July 1998 and located in Ann Arbor, MI. Esperion was acquired by Pfizer in February 2004 for $1.3 billion. A co-inventor of Lipitor(R), he was previously a Distinguished Scientist at Parke Davis Pharmaceutical Research. Mr. Mayleben was most recently the Chief Operating Officer Chief Operating Officer (COO)

The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president.
 of Esperion, which is now a division of Pfizer Global Research & Development. Mr. Mayleben joined Esperion in late 1998 as Chief Financial Officer and was responsible for raising more than $200 million in venture capital and institutional equity funding. "The active involvement of Mssrs. Mayleben and Newton will be fundamental to our plan to develop and commercialize disease modifying therapeutics for the treatment of auto-immune and metabolic diseases," stated Dr. Blake Paterson, Co-founder and CEO.

Dr. Jeffers joins Alba from Connolly, Bove, Lodge and Hutz, L.L.P., Washington, D.C., where he has been involved in the representation of such clients as Pfizer (Lipitor(R)) and Bayer (Kogenate(R)) in crucial patent litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
 cases. Dr. Jeffers earned his Juris Doctorate from Georgetown University, obtained his PhD in Biochemistry and Biophysics biophysics, application of various methods and principles of physical science to the study of biological problems. In physiological biophysics physical mechanisms have been used to explain such biological processes as the transmission of nerve impulses, the muscle  at the University of Houston, and completed NIH "Not invented here." See digispeak.

NIH - The United States National Institutes of Health.
 Postdoctoral Fellowships at the Johns Hopkins University Johns Hopkins University, mainly at Baltimore, Md. Johns Hopkins in 1867 had a group of his associates incorporated as the trustees of a university and a hospital, endowing each with $3.5 million. Daniel C. . "We are delighted to have Chris join the Alba team. He brings strong scientific and legal expertise to the Alba team. He has the abilities to help us advance both the scientific development and intellectual property protection of our technology platform at a crucial time for the Company," stated Dr. Blake Paterson, CEO of Alba Therapeutics Corporation.

Alba Therapeutics is a Baltimore based biopharmaceutical company dedicated to commercializing disease-modifying therapeutics and drug delivery adjuvants based on the zonulin pathway. Alba's lead molecule, AT-1001, is targeted towards the treatment of Celiac Disease and Type 1 Diabetes type 1 diabetes
n.
See diabetes mellitus.
 and is in the final stages of pre-human testing.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 3, 2005
Words:358
Previous Article:NMS Communications to Demonstrate IP Telephony Expertise Through Executive Presentations, Product Demonstrations at Spring VON 2005 Conference & Expo.
Next Article:SkyTerra Communications Announces FCC Ruling for MSV Joint Venture.



Related Articles
Retired Amgen Executive Edward Garnett Named to Business Advisory Board of NeoStem.
The T Sector Magazine and BIOCOM Announce San Diego's 2003 bioFUSION 03 Award Nominees; Life Sciences Innovations, Leaders Headline 2003 Nominees.
Symbol Technologies Names Peter Lieb Senior Vice President, General Counsel and Secretary.
Incyte Announces New General Counsel.
IPI Financial Services Names Three Intellectual Property Experts to Its Board of Advisors.
Alba Therapeutics Corporation Closes on US$30M Series A Financing.
Staktek Names Wayne R. Lieberman Chief Executive Officer; James W. Cady Focuses Full Time on the Role of Chief Technical Officer.
ALM's Corporate Counsel Adds Three Distinguished General Counsel to Editorial Advisory Board.
QD Vision Names Mark Comerford Chief Executive Officer; Quantum-Dot Display Technology Innovator Announces Key Additions to World-Class Team.
Altitude Capital Partners Names Former Apple Computer & National Semiconductor Chief IP Counsel Irving Rappaport to Its Advisory Board.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles